Neonatal Myasthenia Gravis

This is a type of myasthenia gravis that affects newborns. It happens when a baby is born to a mother with myasthenia gravis. The baby might have trouble breathing, sucking, or swallowing right from birth. Usually, the baby's muscles get stronger over time, but sometimes the weakness can last longer.

Condition

What people with Neonatal Myasthenia Gravis report

Every report comes from a Lived member, sent anonymously.

Have you tried Mestinon (Pyridostigmine) for Neonatal Myasthenia Gravis?

NameHow it went

About Neonatal Myasthenia Gravis

What It Is

Neonatal myasthenia gravis is temporary muscle weakness in a newborn whose mother has myasthenia gravis (MG). MG is an autoimmune condition in which antibodies block the signal that tells muscles to contract, so muscles tire and weaken with use. During pregnancy, some of these antibodies cross the placenta, and in a minority of babies they cause the same kind of weakness for a while after birth. Affected babies usually show signs within the first few days of life. They may seem floppy, have a weak cry, or tire, cough or choke while feeding because sucking and swallowing take effort. The most serious concern is weakness of the breathing muscles, which is uncommon but can be dangerous. The baby's body does not make these antibodies and gradually clears the mother's, so the weakness fades over weeks to a few months. This is why the condition is also called transient neonatal myasthenia gravis.

Causes & Risk Factors

The cause is antibodies from a mother with MG reaching the baby before birth. Most babies of mothers with MG are not affected: a 2026 review of studies covering more than 1,500 infants found that about 9 percent developed the condition, and other reports put the figure at 10 to 20 percent. The baby has not inherited MG, and this newborn weakness is not the same as a child developing MG of their own. It is hard to predict which babies will be affected. A mother's MG can be well controlled, or mild enough that it has never been diagnosed, and her baby can still develop weakness. A previously affected baby, and MG caused by MuSK antibodies (antibodies against muscle-specific kinase, a less common type), point toward a more severe course. Some observational studies suggest lower rates when the mother has had her thymus gland removed (thymectomy), but this evidence is limited. Rarely, antibodies that target the fetal form of the muscle receptor act much earlier in pregnancy and limit the baby's movement in the womb. This can cause arthrogryposis multiplex congenita, in which joints are fixed in bent or straightened positions at birth, sometimes with underdeveloped lungs and excess amniotic fluid. Unlike the usual newborn weakness, these effects are often permanent. After such a pregnancy, specialists may discuss treating the mother early in a later pregnancy to try to prevent it.

How It's Diagnosed

When a mother is known to have MG, the diagnosis usually comes from watching the baby closely after birth. Signs most often appear within the first day or two and rarely later than about four days. For that reason, experts recommend that every baby of a mother with MG be examined and observed during this window, with quick access to neonatal intensive care, even when the mother's MG is well controlled. Clinicians watch how the baby feeds, cries, moves and breathes. A blood test for acetylcholine receptor antibodies, the most common MG antibody, can show that the mother's antibodies are present in the baby's blood. When a weak, floppy newborn has no known maternal history, the mother may be tested for MG, because she can carry the antibodies without symptoms. Other causes are considered too. Congenital myasthenic syndromes affect the same nerve-to-muscle connection but are genetic rather than caused by the mother's antibodies, so their symptoms usually start at birth and last for life. Spinal muscular atrophy, inherited muscle diseases and metabolic conditions are other possibilities. Weakness that does not fade on the expected timeline is a reason to look again for one of these conditions.

Treatment Options

Treatment supports the baby until the mother's antibodies are gone. Many affected babies need only close monitoring and help with feeding. If sucking and swallowing are too weak for full feeds, a thin tube passed through the nose into the stomach (a nasogastric tube) can provide milk while the baby gains strength, and feeding by mouth is increased as the weakness eases. Some babies are given pyridostigmine, a medicine used in MG that slows the breakdown of acetylcholine, the chemical messenger muscles respond to, so nerve signals get through more easily. In a newborn it is usually a short course, with the dose set and adjusted by the baby's medical team, and it can help with feeding and strength while the antibodies clear. Babies with breathing weakness are cared for in a neonatal intensive care unit (NICU), where breathing can be monitored and supported. Serious breathing problems are uncommon: in one combined series of 147 babies born to mothers with MG, one needed a breathing tube. For severe cases, doctors may use intravenous immunoglobulin (IVIG), donated antibodies given through a vein, or plasma exchange, which filters antibodies out of the blood.

What to Expect

For most families this is a short episode with a full recovery. Weakness typically lasts about two to three weeks. Around 90 percent of affected babies have recovered completely within two months, and the rest within four months. Babies with mild signs may go home after a few days of observation, while others stay in the hospital until they can feed well and are gaining weight. After discharge, follow-up with the pediatrician focuses on feeding, weight gain and development. The early weeks can also be demanding for the mother, because MG often worsens after delivery. Planning support for both mother and baby before the birth, including help with night feeds and appointments, makes this period easier. A family whose baby was affected has useful information for the future: a later baby may be affected again, sometimes more severely. This is worth discussing with the mother's neurologist and obstetric team before or early in a next pregnancy.

When to Seek Help

If you have MG and are pregnant, tell your obstetric team and plan to give birth where your baby can be watched for the first few days with access to neonatal intensive care. After you go home, contact your baby's doctor the same day if your baby feeds poorly, tires, coughs or chokes during feeds, has a weak cry, seems unusually floppy or has fewer wet diapers. Call 911 if your baby is struggling to breathe, has pauses in breathing or turns blue or gray around the lips.

Questions to Ask Your Doctor

  1. 1.Where should I give birth, and how long will my baby be watched afterward?
  2. 2.What signs would lead the team to start pyridostigmine or move my baby to intensive care?
  3. 3.If my baby needs help feeding, how will we work back to feeding by mouth, and can my baby have breast milk?
  4. 4.Could my antibody type or my earlier pregnancies change my baby's chances of being affected?
  5. 5.What follow-up does my baby need after we go home, and when should we expect full strength?

Last reviewed • Oct 2026

Educational content, not medical advice.